11-66337699-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001024957.2(BRMS1):c.842C>T(p.Ser281Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000395 in 1,598,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001024957.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRMS1 | NM_015399.4 | c.*183C>T | 3_prime_UTR_variant | 10/10 | ENST00000359957.8 | NP_056214.1 | ||
BRMS1 | XM_024448426.2 | c.802C>T | p.Arg268* | stop_gained | 9/9 | XP_024304194.1 | ||
BRMS1 | NM_001024957.2 | c.842C>T | p.Ser281Leu | missense_variant | 10/10 | NP_001020128.1 | ||
BRMS1 | XM_024448425.2 | c.884C>T | p.Ser295Leu | missense_variant | 9/9 | XP_024304193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BRMS1 | ENST00000359957.8 | c.*183C>T | 3_prime_UTR_variant | 10/10 | 1 | NM_015399.4 | ENSP00000353042.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000894 AC: 20AN: 223732Hom.: 0 AF XY: 0.0000822 AC XY: 10AN XY: 121688
GnomAD4 exome AF: 0.000429 AC: 620AN: 1446484Hom.: 0 Cov.: 30 AF XY: 0.000412 AC XY: 296AN XY: 718632
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at